⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8725615 | 0.67 | — | — | |
| SCHEMBL5547954 | 0.61 | — | — | |
| SCHEMBL27623082 | 0.59 | KCNA4 (0.30) | — | |
| SCHEMBL3713102 | 0.59 | — | — | |
| SCHEMBL28005305 | 0.57 | — | — | |
| SCHEMBL18687689 | 0.53 | — | — | |
| SCHEMBL20030014 | 0.52 | — | — | |
| SCHEMBL10592329 | 0.49 | — | — | |
| SCHEMBL27570798 | 0.49 | — | — | |
| SCHEMBL651428 | 0.46 | MEN1 (0.75) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090162293-A1 | METHODS AND COMPOSITIONS FOR ULTRASOUND IMAGING OF APOPTOSIS | POINT BIOMEDICAL CORPORATION (US) | 2009-06-25 | — | — | US | disclosed |
| EP-1673108-A4 | METHODS AND COMPOSITIONS FOR ULTRASOUND IMAGING OF APOPTOSIS | POINT BIOMEDICAL CORP (US) | 2009-06-03 | — | — | EP | disclosed |
| US-7413727-B2 | Contrast agents | GE HEALTHCARE AS (NO) | 2008-08-19 | — | — | US | disclosed |
| EP-1442751-B1 | Diagnostic imaging technique | GE HEALTHCARE AS (NO) | 2007-06-20 | — | — | EP | disclosed |
| US-7182934-B2 | Ultrasonic contrast agents; aqueous suspension | GE HEALTHCARE AS (NO) | 2007-02-27 | — | — | US | disclosed |
| EP-1673108-A2 | METHODS AND COMPOSITIONS FOR ULTRASOUND IMAGING OF APOPTOSIS | Point Biomedical Corporation (US) | 2006-06-28 | — | — | EP | disclosed |
| EP-1007101-B1 | IMPROVEMENTS IN OR RELATING TO DIAGNOSTIC/THERAPEUTIC AGENTS | GE HEALTHCARE AS (NO) | 2006-05-17 | — | — | EP | disclosed |
| EP-0973552-B1 | IMPROVEMENTS IN OR RELATING TO DIAGNOSTIC/THERAPEUTIC AGENTS | AMERSHAM HEALTH AS (NO) | 2006-03-01 | — | — | EP | disclosed |
| EP-0971747-B1 | CONTRAST AGENTS | AMERSHAM HEALTH AS (NO) | 2005-12-28 | — | — | EP | disclosed |
| US-20050201930-A1 | Contrast agents | GE HEALTHCARE AS (NO) | 2005-09-15 | — | — | US | disclosed |
| EP-0977600-A2 | CONTRAST AGENTS | NYCOMED IMAGING A/S (NO) | 2000-02-09 | — | — | EP | disclosed |
| EP-0971747-A2 | CONTRAST AGENTS | NYCOMED IMAGING AS (NO) | 2000-01-19 | — | — | EP | disclosed |
| EP-0963209-A2 | IMPROVEMENTS IN OR RELATING TO DIAGNOSTIC/THERAPEUTIC AGENTS | Marsden, John Christopher (GB) | 1999-12-15 | — | — | EP | disclosed |
| EP-0946202-A2 | CONTRAST AGENTS | NYCOMED IMAGING AS (NO) | 1999-10-06 | — | — | EP | disclosed |
| WO-1998047541-A1 | CONTRAST AGENTS | NYCOMED IMAGING AS (NO) | 1998-10-29 | — | — | WO | disclosed |
| WO-1998018497-A2 | CONTRAST AGENTS | NYCOMED IMAGING AS (NO) | 1998-05-07 | — | — | WO | disclosed |
| WO-1998018496-A2 | CONTRAST AGENTS | NYCOMED IMAGING AS (NO) | 1998-05-07 | — | — | WO | disclosed |
| WO-1998018500-A2 | IMPROVEMENTS IN OR RELATING TO DIAGNOSTIC/THERAPEUTIC AGENTS | MARSDEN, JOHN, CHRISTOPHER (GB) | 1998-05-07 | — | — | WO | disclosed |
| WO-1998018498-A2 | IMPROVEMENTS IN OR RELATING TO DIAGNOSTIC/THERAPEUTIC AGENTS | MARSDEN, JOHN, CHRISTOPHER (GB) | 1998-05-07 | — | — | WO | disclosed |
| WO-1998018495-A2 | IMPROVEMENTS IN OR RELATING TO DIAGNOSTIC/THERAPEUTIC AGENTS | MARSDEN, JOHN, CHRISTOPHER (GB) | 1998-05-07 | — | — | WO | disclosed |